alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › brain-endothelial

brain-endothelial

2 studies tagged brain-endothelial, dated 2024-12-16 to 2026-06-26. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Brain Endothelial Glycocalyx as a Blood-Facing Translational Interface in Alzheimer's Disease: Beyond "Leaky" Barriers Toward Repair-First Stratification 2026-06-26
  2. Insights into the transcriptomic heterogeneity of brain endothelial cells in normal aging and Alzheimer's disease 2024-12-16

Studies

2 studies carry this tag.

Date range

2024 to 2026

Top journals

  • Drug design, development and therapy 1
  • Neural regeneration research 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Brain Endothelial Glycocalyx as a Blood-Facing Translational Interface in Alzheimer's Disease: Beyond "Leaky" Barriers Toward Repair-First Stratification

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Drug design, development and therapy 2026-06-26 Treatments

    Alzheimer's disease (AD) pathogenesis is increasingly recognized as involving blood-brain barrier (BBB) and neurovascular unit (NVU) destabilization.

  2. Insights into the transcriptomic heterogeneity of brain endothelial cells in normal aging and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Neural regeneration research 2024-12-16 Treatments

    Drug development for Alzheimer's disease is extremely challenging, as demonstrated by the repeated failures of amyloid-β-targeted therapeutics and the controversies surrounding the amyloid-β cascade hypothesis.

All topic tags with their study counts